Citigroup’s Cytosorbents Corp CTSO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-420
| Closed | -$1K | – | 5027 |
|
|
2022
Q2 | $1K | Sell |
420
-1,064
| -72% | -$2.53K | ﹤0.01% | 5187 |
|
|
2022
Q1 | $5K | Sell |
1,484
-9,331
| -86% | -$31.4K | ﹤0.01% | 4984 |
|
|
2021
Q4 | $45K | Buy |
10,815
+5,870
| +119% | +$24.4K | ﹤0.01% | 4347 |
|
|
2021
Q3 | $40K | Buy |
4,945
+2,983
| +152% | +$24.1K | ﹤0.01% | 4113 |
|
|
2021
Q2 | $15K | Sell |
1,962
-757
| -28% | -$5.79K | ﹤0.01% | 4783 |
|
|
2021
Q1 | $24K | Sell |
2,719
-5,113
| -65% | -$45.1K | ﹤0.01% | 4467 |
|
|
2020
Q4 | $62K | Buy |
7,832
+5,859
| +297% | +$46.4K | ﹤0.01% | 3972 |
|
|
2020
Q3 | $16K | Sell |
1,973
-2,709
| -58% | -$22K | ﹤0.01% | 4062 |
|
|
2020
Q2 | $46K | Sell |
4,682
-4,137
| -47% | -$40.6K | ﹤0.01% | 3811 |
|
|
2020
Q1 | $68K | Buy |
8,819
+2,531
| +40% | +$19.5K | ﹤0.01% | 3547 |
|
|
2019
Q4 | $24K | Buy |
6,288
+2,166
| +53% | +$8.27K | ﹤0.01% | 4405 |
|
|
2019
Q3 | $21K | Sell |
4,122
-4,455
| -52% | -$22.7K | ﹤0.01% | 4248 |
|
|
2019
Q2 | $57K | Buy |
8,577
+531
| +7% | +$3.53K | ﹤0.01% | 3984 |
|
|
2019
Q1 | $61K | Buy |
8,046
+1,096
| +16% | +$8.31K | ﹤0.01% | 3894 |
|
|
2018
Q4 | $56K | Sell |
6,950
-1,223
| -15% | -$9.85K | ﹤0.01% | 3834 |
|
|
2018
Q3 | $105K | Buy |
8,173
+4,096
| +100% | +$52.6K | ﹤0.01% | 3545 |
|
|
2018
Q2 | $46K | Buy |
+4,077
| New | +$46K | ﹤0.01% | 3920 |
|
|
2016
Q2 | – | Sell |
-167
| Closed | -$1K | – | 4991 |
|
|
2016
Q1 | $1K | Buy |
+167
| New | +$1K | ﹤0.01% | 5180 |
|
|
2015
Q4 | – | Sell |
-406
| Closed | -$3K | – | 5430 |
|
|
2015
Q3 | $3K | Sell |
406
-381
| -48% | -$2.82K | ﹤0.01% | 4794 |
|
|
2015
Q2 | $5K | Buy |
+787
| New | +$5K | ﹤0.01% | 4826 |
|